5%+ major-holding disclosures
- 마크로젠56.34%2025-11-06 · 증감 0.00%p
Psomagen
A950200 · KOSDAQ₩2,845+1.61%
2026-08-06 closeLoading chart…
Close
AI Insight
Why these signals fired — only backtest-proven edge, told honestly
Strong-buy signal — the real recordrecord · not a prediction
Not this one stock, but every strong-buy pick we actually published (Korea market). When this stock flashes the signal, it is treated by the same rule.(as of 2026-08-06)
Last 30 sessions
520 picks
Next-day win rate
49%
Avg next-day
-0.17%
vs market
-0.07%p
Beat the market on 50.5% of picks (each pick vs its own day’s market average).
Recent publish days (next-day win rate)
08-05 25%08-04 100%08-03 0%07-31 0%07-30 66.7%07-29 0%07-28 45%07-27 20%07-25 36.4%07-21 55.6%07-20 53.8%07-16 53.3%
This stock has not flashed this signal recently — the record above is the signal’s own, not this stock’s.
Entry is the latest close at publish time; next-day is the following close. “Market” is the equal-weighted average of every stock in the same market that day; delisted names are excluded from both. Fees, taxes and slippage are not included. An observed record over a short window, not a pre-registered backtest. Not investment advice.
Key suppliers · Annual report
Annual reportDART · 2026-03-23Suppliers disclosed by the company in its 2026-03-23 annual report.
Suppliers without disclosed amount
USDNGSDTCMicrobiomeHiSeqXReagentNovaSeqReagentPlusBReagentCycleCES+5 more
Financials at a glance
Psomagen's latest results and balance sheet. The bars track the last three periods.
Who held it · filings
Filed recordA historical record from curated-guru 13F filings and DART 5%+ major-holding disclosures.
US 13F는 분기 공시이며 최대 45일 뒤 제출될 수 있습니다.
Connections
AI-extracted related companies · for reference
Suppliers
Customers
National Cancer InstituteNIH
Competitors
Same theme
FDAPrecision medicineNGS
Recent filings
Psomagen's latest filings on Korea's DART. Open a headline for a reference summary and the original.
Source: DART (Korea electronic disclosure)
Like these rules? Run them automatically.
Quantus turns rules like these into backtests and automated trading — same team, free to start.
Quantus Signal · live data · not investment advice · Privacy Policy